Demis Hassabis (DeepMind CEO) and other AI leaders sees the next big AI gains—and the path to AGI—will come from targeted ...
In total, 5,708 patients from five randomized phase III trials were included. Two MMAI algorithms were evaluated: (1) the distant metastasis (DM) MMAI model optimized to predict risk of DM, and (2) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果